https://finance.yahoo.com/news/phase-3-data-aprocitentan-patients-154500135.html
0
0
New Phase 3 data with aprocitentan for patients with resistant hypertension has been presented at the European Society of Hypertension Annual Meeting 2023 - Yahoo Finance
+ 8 more
6/26/23 at 3:45pm
Organization
Yahoo Entertainment
Author
Idorsia Pharmaceuticals Ltd
Details
46 words
Summarize
Health Health Conditions aprocitentan Idorsia Ltd European Society of Hypertension Annual Meeting 2023 - Yahoo Finance Allschwil Swiss endothelin
Allschwil, Switzerland – June 26, 2023 Idorsia Ltd (SIX: IDIA) today announced that further data for aprocitentan, Idorsia’s investigational dual endothelin ...
Create an account or login to join the discussion